We provide objective biological data that offers additional context regarding a client's neurological status. Our testing solutions complement existing medical records and clinical evaluations, helping attorneys and case managers better understand, document, and support their clients throughout the care journey.
Annual TBI incidence
Adults live with a TBI-related disability
Of adults that sustain a brain injury never receive care
Of standard CT scans return normal results where brain injury is clinically evident

A licensed healthcare provider orders the test kit through our online provider portal.

Blood samples are collected through a simple blood draw using one of three convenient options: in-office collection (if offered by your provider), mobile phlebotomy, or an outpatient collection site.
*Blood collection options are based on provider preference and availability in your client’s area.

Your client’s sample is shipped to our CLIA-certified and CAP-accredited laboratory using prepaid shipping materials included with the test kit.

Results are returned to the ordering healthcare provider within 7–10 business days and include educational notes that may help support client discussions and care coordination.

A licensed healthcare provider orders the test kit through our online provider portal.

Blood samples are collected through a simple blood draw using one of three convenient options: in-office collection (if offered by your provider), mobile phlebotomy, or an outpatient collection site.
*Blood collection options are based on provider preference and availability in your client’s area.

Your client’s sample is shipped to our CLIA-certified and CAP-accredited laboratory using prepaid shipping materials included with the test kit.

Results are returned to the ordering healthcare provider within 7–10 business days and include educational notes that may help support client discussions and care coordination.
Protein biomarkers and genetic markers providing objective biological data on cellular injury, change, and neurological risk factors.
GFAP • UCH-L1 • S100β • NF-H
APOE • MTHFR
Genetic markers are evaluated once because DNA remains constant throughout life.
Designed for longitudinal monitoring using protein biomarkers associated with cellular injury and change.
GFAP • UCH-L1 • S100β • NF-H
A forthcoming panel evaluating hormones associated with neuroendocrine function and change.
Protein biomarkers and genetic markers providing objective biological data on cellular injury, change, and neurological risk factors.
GFAP • UCH-L1 • S100β • NF-H
APOE • MTHFR
Genetic markers are evaluated once because DNA remains constant throughout life.
Designed for longitudinal monitoring using protein biomarkers associated with cellular injury and change.
GFAP • UCH-L1 • S100β • NF-H
A forthcoming panel evaluating hormones associated with neuroendocrine function and change.
Protein biomarkers and genetic markers providing objective biological data on cellular injury, change, and neurological risk factors.
GFAP • UCH-L1 • S100β • NF-H
APOE • MTHFR
Genetic markers are evaluated once because DNA remains constant throughout life.
Designed for longitudinal monitoring using protein biomarkers associated with cellular injury and change.
GFAP • UCH-L1 • S100β • NF-H
A forthcoming panel evaluating hormones associated with neuroendocrine function and change.
Protein biomarkers and genetic markers providing objective biological data on cellular injury, change, and neurological risk factors.
GFAP • UCH-L1 • S100β • NF-H
APOE • MTHFR
Genetic markers are evaluated once because DNA remains constant throughout life.
Designed for longitudinal monitoring using protein biomarkers associated with cellular injury and change.
GFAP • UCH-L1 • S100β • NF-H
A forthcoming panel evaluating hormones associated with neuroendocrine function and change.
Our team helps coordinate each step of the testing process, from scheduling your client’s blood draw to delivering results to their healthcare provider.
Your client’s information is protected through HIPAA-compliant processes designed to safeguard your client’s privacy and security.
CAP accreditation, CLIA certification, and validated testing methodologies reflect our dedication to quality, accuracy, and the delivery of reliable neurodiagnostic information.
Flexible blood collection methods, including in-office, mobile, and outpatient phlebotomy blood collection, help make your client’s testing process simple and accessible.
